Capmatinib Global Pricing Overview and Buying Guide

Capmatinib (Capmatinib) is an innovative drug designed to treat a specific type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. As a kinase inhibitor, it slows or halts the spread of cancer cells by blocking the activity of abnormal proteins that send growth signals to cancer cells.

Capmatinib is taken as an oral tablet and is usually recommended twice daily with or without meals. To ensure the best effect, patients should try to take the medicine at the same time every day and strictly follow the doctor's prescribed dosage. Do not take more or less. Tablets should be swallowed whole and avoid cutting, chewing or crushing. If vomiting occurs after taking the medicine, there is no need to take a supplementary dose, just continue taking the medicine according to the established plan. During the treatment process, doctors will flexibly adjust the drug dosage or suspend treatment based on the patient's response and side effects.

Regarding the price of capmatinib, since the original drug is not yet on the market in China, it is not covered by medical insurance. In Hong Kong, a box of medicine with a specification of 200mg60 costs more than 30,000 yuan. In overseas markets, especially Europe, the price of medicines of the same specifications even exceeds 50,000 yuan, and the specific price will be affected by exchange rate changes. However, for patients seeking more affordable options, lower-priced generic versions of capmatinib are also available in overseas markets. For example, a 200mg56 generic drug produced in Laos costs only more than 3,000 yuan per box. Although the price may be subject to exchange rate fluctuations, the cost is significantly lower than that of the original drug. And the pharmaceutical ingredients of capmatinib generic drugs are basically the same as those of the original drug.